Search Results - "Illes, Z"

EFNS guidelines on diagnosis and management of neuromyelitis optica by Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illes, Z., Montalban, X., Du Pasquier, R. A., Polman, C. H., Sorensen, P. S., Hemmer, B.

“…Background and purpose:  Neuromyelitis optica (NMO) or Devic′s disease is a rare inflammatory and demyelinating autoimmune disorder of the central nervous…”
Get full text

Teriflunomide for multiple sclerosis in real‐world setting by Elkjaer, M. L., Molnar, T., Illes, Z.

“…Objectives Teriflunomide 14 mg is a once‐daily oral disease‐modifying treatment for relapsing‐remitting multiple sclerosis. We examined adverse event (AE)…”
Get full text

Treatment of MOG antibody associated disorders: results of an international survey by Whittam, D. H., Karthikeayan, V., Gibbons, E., Kneen, R., Chandratre, S., Ciccarelli, O., Hacohen, Y., de Seze, J., Deiva, K., Hintzen, R. Q., Wildemann, B., Jarius, S., Kleiter, I., Rostasy, K., Huppke, P., Hemmer, B., Paul, F., Aktas, O., Pröbstel, A. K., Arrambide, G., Tintore, M., Amato, M. P., Nosadini, M., Mancardi, M. M., Capobianco, M., Illes, Z., Siva, A., Altintas, A., Akman-Demir, G., Pandit, L., Apiwattankul, M., Hor, J. Y., Viswanathan, S., Qiu, W., Kim, H. J., Nakashima, I., Fujihara, K., Ramanathan, S., Dale, R. C., Boggild, M., Broadley, S., Lana-Peixoto, M. A., Sato, D. K., Tenembaum, S., Cabre, P., Wingerchuk, D. M., Weinshenker, B. G., Greenberg, B., Matiello, M., Klawiter, E. C., Bennett, J. L., Wallach, A. I., Kister, I., Banwell, B. L., Traboulsee, A., Pohl, D., Palace, J., Leite, M. I., Levy, M., Marignier, R., Solomon, T., Lim, M., Huda, S., Jacob, A.

“…Introduction While monophasic and relapsing forms of myelin oligodendrocyte glycoprotein antibody associated disorders (MOGAD) are increasingly diagnosed…”
Get full text

A population‐based epidemiological study of neuromyelitis optica spectrum disorder in Hungary by Papp, V., Iljicsov, A., Rajda, C., Magyari, M., Koch‐Henriksen, N., Petersen, T., Jakab, G., Deme, I., Nagy, F., Imre, P., Lohner, Z., Kovács, K., Birkás, A. J., Köves, Á., Rum, G., Nagy, Z., Kerényi, L., Vécsei, L., Bencsik, K., Jobbágy, Z., Diószeghy, P., Horváth, L., Galántai, G., Kasza, J., Molnár, G., Simó, M., Sátori, M., Rózsa, C., Ács, P., Berki, T., Lovas, G., Komoly, S., Illes, Z.

“…Background and purpose The goal of this study was to determine the prevalence and incidence of neuromyelitis optica spectrum disorder (NMOSD) in Hungary based…”
Get full text

Autoimmune encephalitis associated with voltage‐gated potassium channels‐complex and leucine‐rich glioma‐inactivated 1 antibodies – a national cohort study by Celicanin, M., Blaabjerg, M., Maersk‐Moller, C., Beniczky, S., Marner, L., Thomsen, C., Bach, F. W., Kondziella, D., Andersen, H., Somnier, F., Illes, Z., Pinborg, L. H.

“…Background and purpose The aim of this study was to describe clinical and paraclinical characteristics of all Danish patients who tested positive for…”
Get full text

Cladribine modifies functional properties of microglia by Jørgensen, L. Ø., Hyrlov, K. H., Elkjaer, M. L., Weber, A. B., Pedersen, A. E., Svenningsen, Å. Fex, Illes, Z.

“…Summary Cladribine (CdA), an oral prodrug approved for the treatment of relapsing multiple sclerosis, selectively depletes lymphocytes. CdA passes the…”
Get full text

Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system by Banati, M., Csecsei, P., Koszegi, E., Nielsen, H. H., Suto, G., Bors, L., Trauninger, A., Csepany, T., Rozsa, C., Jakab, G., Molnar, T., Berthele, A., Kalluri, S. R., Berki, T., Illes, Z.

“…Background Antibodies against gastrointestinal antigens may indicate altered microbiota and immune responses in the gut. Recent experimental data suggest a…”
Get full text

Patient reported outcomes in a secondary progressive MS cohort related to cognition, MRI and physical outcomes by Theodorsdottir, A, Nielsen, HH, Ravnborg, MH, Illes, Z

“…•Patient-reported outcomes (PROs) correlate with functional tests/scales in SPMS.•In contrast, PROs poorly correlate with cognition, and MRI outcomes in…”
Get full text

Identification of a novel HLA‐B allele, HLA‐B08:177, in a Hungarian patient and her HLA identical sibling by Inotai, D., Illés, Z., Szabó, E., Varga, Á., Szilvási, A.

“…The newly detected HLA‐B*08:177 differs from HLA‐B*08:01:01:01 by 1 single nucleotide substitution at position 365 of exon 3…”
Get full text

Social cognition and Theory of Mind in patients with relapsing-remitting multiple sclerosis by Banati, M., Sandor, J., Mike, A., Illes, E., Bors, L., Feldmann, A., Herold, R., Illes, Z.

“…Background:  Theory of Mind (ToM) is an ability to understand and interpret another person’s beliefs, emotions, and intentions. ToM requires both cognitive and…”
Get full text

Differential expression of NK T cell V alpha 24J alpha Q invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy by Illés, Z, Kondo, T, Newcombe, J, Oka, N, Tabira, T, Yamamura, T

“…Human V alpha 24+ NK T cells are a unique subset of lymphocytes expressing the V alpha 24J alpha Q invariant TCR chain. Because they can rapidly produce large…”
Get full text

Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death by Veto, Sara, Acs, Peter, Bauer, Jan, Lassmann, Hans, Berente, Zoltan, Setalo, Gyorgy, Borgulya, Gabor, Sumegi, Balazs, Komoly, Samuel, Gallyas, Ferenc, Illes, Zsolt

“…Oligodendrocyte loss and demyelination are major pathological hallmarks of multiple sclerosis. In pattern III lesions, inflammation is minor in the early…”
Get full text

High anti-EBNA-1 IgG levels are associated with early-onset myasthenia gravis by Csuka, D., Banati, M., Rozsa, C., Füst, G., Illes, Z.

“…Background:  Myasthenia gravis (MG) is an autoimmune disorder mediated by antibodies against the acethylcholine receptor (AchR) of the neuromuscular junction…”
Get full text

l -Arginine Pathway Metabolites Predict Need for Intra-operative Shunt During Carotid Endarterectomy by Szabo, P, Lantos, J, Nagy, L, Keki, S, Volgyi, E, Menyhei, G, Illes, Z, Molnar, T

“…Objective/Background Asymmetric dimethylarginine (ADMA) inhibits nitric oxide (NO) synthesis and is a marker of atherosclerosis. This study examined the…”
Get full text

T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis by Khademi, Mohsen, Illes, Zsolt, Gielen, Alexander W, Marta, Monica, Takazawa, Naruhiko, Baecher-Allan, Claire, Brundin, Lou, Hannerz, Jan, Martin, Claes, Harris, Robert A, Hafler, David A, Kuchroo, Vijay K, Olsson, Tomas, Piehl, Fredrik, Wallstrom, Erik

“…T cell Ig- and mucin-domain-containing molecules (TIMs) comprise a recently described family of molecules expressed on T cells. TIM-3 has been shown to be…”
Get full text

Long-lasting airplane headache in a patient with chronic rhinosinusitis by Pfund, Z, Trauninger, A, Szanyi, I, Illes, Z

“…The authors report long-lasting airplane headache in a patient with non-allergic, chronic rhinosinusitis. Association of mucosal inflammation with compromised…”
Get more information

Accumulation of V 7.2-J 33 invariant T cells in human autoimmune inflammatory lesions in the nervous system by Illes, Z.

“…T cells expressing an invariant TCR ± chain and NK cell markers are expected to exhibit unique functions. Whereas much attention has been paid to…”
Get full text

The significance of Galectin-9/TIM-3 pathway in mifepristone induced medical abortion in BALB/c mice by Meggyes, M, Lajko, A, Miko, E, Illes, Z, Szekeres-Bartho, J, Szereday, L

Get full text

Decrease in Cold Ischemic Times as a Result of Protocol Changes of Urgent Immunogenetic Testing During Cadaveric Kidney Transplantation in Hungary by Inotai, D, Boros-Major, A, Illés, Z, Szilvási, A, Nagy, G, Rajczy, K, Chmel, R, Langer, R.M, Tordai, A

“…Abstract Background Based on national ethics committee permission, the procedure of urgent immunogenetics testing prior to cadaveric kidney transplantation was…”
Get full text

Long-term effects of combined immunosuppressive treatment on myasthenic crisis by Rózsa, C., Mikor, A., Kasa, K., Illes, Z., Komoly, S.

“…Background and purpose:  We studied the long‐term crisis‐preventing effect of combined prednisolone‐azathioprine (PR‐AZA) treatment in myasthenia gravis (MG)…”
Get full text